Prescribing curbs for seven more products

Recommendations to restrict the prescribing of a further seven items currently available in primary care were approved by the NHS England board at its meeting in June.

This follows the outcome of a public consultation between November 2018 and February 2019. Newly restricted items include:

  • Aliskiren
  • Amiodarone
  • Emollient bath & shower preparations for dry and pruritic skin conditions
  • Dronedarone
  • Minocycline for acne
  • Silk garments
  • Needles for pre-filled and reusable insulin pens

The proposals initially included the removal of blood glucose testing strips for type 2 diabetes mellitus, but following the consultation these will remain available by routine prescription while further work is done to compare the quality of the different products available.

Updated guidance has been provided to CCGs.

Recommended

Pharmacists among new group of diabetes clinical champions

Drug alert: Defect in Emerade devices




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.